Stephan Klauke

429 total citations
24 papers, 332 citations indexed

About

Stephan Klauke is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Stephan Klauke has authored 24 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 16 papers in Virology and 8 papers in Emergency Medicine. Recurrent topics in Stephan Klauke's work include HIV Research and Treatment (16 papers), HIV/AIDS drug development and treatment (16 papers) and HIV/AIDS Research and Interventions (8 papers). Stephan Klauke is often cited by papers focused on HIV Research and Treatment (16 papers), HIV/AIDS drug development and treatment (16 papers) and HIV/AIDS Research and Interventions (8 papers). Stephan Klauke collaborates with scholars based in Germany, United States and United Kingdom. Stephan Klauke's co-authors include Schlomo Staszewski, Markus Bickel, Christoph Stephan, Thomas A. Lutz, Peter Gute, Andrew Phillips, Caroline Sabin, Veronica Miller, Annette Haberl and Hans Wilhelm Doerr and has published in prestigious journals such as The Journal of Infectious Diseases, Antimicrobial Agents and Chemotherapy and AIDS.

In The Last Decade

Stephan Klauke

24 papers receiving 310 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stephan Klauke Germany	10	252	201	90	75	49	24	332
Margherita Bracchi United Kingdom	7	187 0.7×	126 0.6×	75 0.8×	98 1.3×	29 0.6×	25	268
Fabienne Caby France	9	232 0.9×	231 1.1×	123 1.4×	92 1.2×	18 0.4×	26	365
Eugénio Teófilo Portugal	9	254 1.0×	178 0.9×	63 0.7×	74 1.0×	12 0.2×	22	319
S Staszewski Germany	8	393 1.6×	268 1.3×	221 2.5×	96 1.3×	28 0.6×	25	494
Veronique Obry‐Roguet France	8	118 0.5×	67 0.3×	74 0.8×	72 1.0×	35 0.7×	12	211
Paola Corsi Italy	14	353 1.4×	321 1.6×	73 0.8×	106 1.4×	16 0.3×	30	448
Federica Tordato Italy	11	186 0.7×	87 0.4×	87 1.0×	100 1.3×	21 0.4×	20	339
J Lange Netherlands	9	193 0.8×	147 0.7×	56 0.6×	55 0.7×	16 0.3×	17	248
Andrzéj Horban United Kingdom	11	365 1.4×	286 1.4×	106 1.2×	171 2.3×	92 1.9×	18	505
Elisabetta Chiesa Italy	11	306 1.2×	242 1.2×	96 1.1×	63 0.8×	14 0.3×	17	351

Countries citing papers authored by Stephan Klauke

Since Specialization

Citations

This map shows the geographic impact of Stephan Klauke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephan Klauke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephan Klauke more than expected).

Fields of papers citing papers by Stephan Klauke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephan Klauke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephan Klauke. The network helps show where Stephan Klauke may publish in the future.

Co-authorship network of co-authors of Stephan Klauke

This figure shows the co-authorship network connecting the top 25 collaborators of Stephan Klauke. A scholar is included among the top collaborators of Stephan Klauke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephan Klauke. Stephan Klauke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wolf, Eva, Knud Schewe, Stephan Klauke, et al.. (2020). Cost of Human Immunodeficiency Virus (HIV) and Determinants of Healthcare Costs in HIV-Infected Treatment-Naive Patients Initiated on Antiretroviral Therapy in Germany: Experiences of the PROPHET Study. Value in Health. 23(10). 1324–1331. 5 indexed citations

Bickel, Markus, Christian Hoffmann, Eva Wolf, et al.. (2020). High effectiveness of recommended first-line antiretroviral therapies in Germany: a nationwide, prospective cohort study. Infection. 48(3). 453–461. 10 indexed citations

Fraunholz, Ingeborg, Annette Haberl, Stephan Klauke, Peter Gute, & Claus Rödel. (2014). Long-term Effects of Chemoradiotherapy for Anal Cancer in Patients With HIV Infection. Diseases of the Colon & Rectum. 57(4). 423–431. 29 indexed citations

Kuhlmann, Alexander, Thomas Mittendorf, Martin Hower, et al.. (2014). Krankheitskosten von HIV-Patienten unter antiretroviraler Therapie in Deutschland – Ergebnisse einer 48-Wochen-Interimsanalyse im Rahmen der prospektiven multizentrischen Kohortenstudie „CORSAR“. Das Gesundheitswesen. 77(6). e133–e142. 7 indexed citations

Stephan, Christoph, Markus Bickel, Annette Haberl, et al.. (2010). Intensification of a failing regimen with zidovudine may cause sustained virologic suppression in the presence of resensitising mutations including K65R. Journal of Infection. 61(4). 346–350. 5 indexed citations

Bickel, Markus, Christoph Stephan, Nils von Hentig, et al.. (2009). Once-daily treatment with saquinavir mesylate (2000 mg) and ritonavir (100 mg) together with a fixed-dose combination of abacavir/lamivudine (600/300 mg) or tenofovir/emtricitabine (245/200 mg) in HIV-1-infected patients. Journal of Antimicrobial Chemotherapy. 64(6). 1260–1264. 1 indexed citations

Stephan, Christoph, et al.. (2009). Quadruple Nucleos(t)ide Reverse Transcriptase Inhibitors-Only Regimen of Tenofovir Plus Zidovudine/Lamivudine/Abacavir in Heavily Pre-Treated HIV-1 Infected Patients: Salvage Therapy or Backbone Only?. Current HIV Research. 7(3). 320–326. 7 indexed citations

Bickel, Markus, Christoph Stephan, Catherine M. Crespi, et al.. (2007). A standardized, comprehensive magnetic resonance imaging protocol for rapid and precise quantification of HIV‐1‐associated lipodystrophy. HIV Medicine. 8(7). 413–419. 4 indexed citations

Graff, Jochen, Nils von Hentig, Carlo Angioni, et al.. (2007). Significant effects of tipranavir on platelet aggregation and thromboxane B2 formation in vitro and in vivo. Journal of Antimicrobial Chemotherapy. 61(2). 394–399. 17 indexed citations

10.

Bickel, Markus, Stephan Zangos, Thomas A. Lutz, et al.. (2007). Long-term effect on body composition and metabolic parameters after treatment with recombinant human growth hormone (r-hGH) in HIV-1 infected patients with lipodystrophy. Scandinavian Journal of Infectious Diseases. 40(1). 36–39. 1 indexed citations

11.

Hentig, Nils von, Axel H. E. Müller, Timo Wolf, et al.. (2007). Pharmacokinetics of Saquinavir, Atazanavir, and Ritonavir in a Twice-Daily Boosted Double-Protease Inhibitor Regimen. Antimicrobial Agents and Chemotherapy. 51(4). 1431–1439. 19 indexed citations

12.

Bickel, Markus, Stephan Zangos, Volkmar Jacobi, et al.. (2006). A randomized, open‐label study to compare the effects of two different doses of recombinant human growth hormone on fat reduction and fasting metabolic parameters in HIV‐1‐infected patients with lipodystrophy. HIV Medicine. 7(6). 397–403. 11 indexed citations

13.

Staszewski, Schlomo, Christoph Stephan, Annette Haberl, et al.. (2006). The LOPSAQ study: 48 week analysis of a boosted double protease inhibitor regimen containing lopinavir/ritonavir plus saquinavir without additional antiretroviral therapy. Journal of Antimicrobial Chemotherapy. 58(5). 1024–1030. 29 indexed citations

14.

Stephan, Christoph, Annemarie Berger, Amina Carlebach, et al.. (2005). Impact of tenofovir-containing antiretroviral therapy on chronic hepatitis B in a cohort co-infected with human immunodeficiency virus. Journal of Antimicrobial Chemotherapy. 56(6). 1087–1093. 30 indexed citations

15.

Klauke, Stephan, et al.. (2005). Use of bioelectrical impedance analysis to determine body composition changes in HIV-associated wasting. International Journal of STD & AIDS. 16(4). 307–313. 5 indexed citations

16.

Stephan, Christoph, Nils von Hentig, Irene S. Kourbeti, et al.. (2004). Saquinavir drug exposure is not impaired by the boosted double protease inhibitor combination of lopinavir/ritonavir. AIDS. 18(3). 503–508. 45 indexed citations

17.

Phillips, Andrew, Schlomo Staszewski, Fiona Lampe, et al.. (2002). Human Immunodeficiency Virus Rebound after Suppression to <400 Copies/mL during Initial Highly Active Antiretroviral Therapy Regimens, according to Prior Nucleoside Experience and Duration of Suppression. The Journal of Infectious Diseases. 186(8). 1086–1091. 36 indexed citations

18.

Phillips, Andrew, Veronica Miller, Caroline Sabin, et al.. (2001). Durability of HIV-1 viral suppression over 3.3 years with multi-drug antiretroviral therapy in previously drug-naive individuals. AIDS. 15(18). 2379–2384. 54 indexed citations

19.

Klauke, Stephan, et al.. (1997). Use of bioelectrical impedance analysis to determine changes in body composition in patients with HIV-associated wasting. Nutrition. 13(3). 285–285. 2 indexed citations

20.

Falkenbach, A., et al.. (1990). Abnormalities in cholesterol metabolism cause peripheral neuropathy and dementia in AIDS—A hypothesis. Medical Hypotheses. 33(1). 57–61. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact